DHR vs VRT: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Vertiv Holdings Co · Industrials
$333.05
-45.0% upside to fair value
Grade D
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
VRT |
| Current Price |
$177.17 |
$333.05 |
| Fair Value Estimate |
$192.90 |
$183.18 |
| Upside to Fair Value |
+8.9%
|
-45.0%
|
| Market Cap |
$125.4B |
$127.9B |
| Forward P/E |
34.1x
|
81.8x
|
| EV / EBITDA |
20.8x
|
55.4x
|
| Price / Sales |
5.1x
|
11.8x
|
| Price / FCF |
23.7x
|
55.4x
|
| Revenue Growth YoY |
+3.7%
|
+30.1%
|
| Gross Margin |
60.7%
|
36.2%
|
| Operating Margin |
21.0%
|
18.5%
|
| Return on Equity |
7.1%
|
42.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
1.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Vertiv Holdings Co operates in the industrials sector, specializing in electrical equipment and parts with a strong focus on data center critical infrastructure. The company benefits from a durable competitive position supported by a broad product portfolio that drives approximately 75% of sales from data centers. Vertiv's business quality is high, demonstrated by a 42.1% return on equity, strong…
Accumulation Zones
| Metric |
DHR |
VRT |
| Zone Low |
$144.68 |
$137.38 |
| Zone High |
$163.97 |
$155.70 |
| In Buy Zone? |
No
|
No
|